Baltimore Washington Financial Advisors Inc. Sells 1,582 Shares of UnitedHealth Group Incorporated $UNH

Baltimore Washington Financial Advisors Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 23,611 shares of the healthcare conglomerate’s stock after selling 1,582 shares during the period. Baltimore Washington Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $7,366,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in UNH. HHM Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after acquiring an additional 26 shares in the last quarter. Hemington Wealth Management boosted its stake in UnitedHealth Group by 2.5% in the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after purchasing an additional 28 shares in the last quarter. Tlwm increased its stake in shares of UnitedHealth Group by 1.0% in the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after buying an additional 28 shares in the last quarter. MGO One Seven LLC lifted its position in UnitedHealth Group by 0.3% during the 1st quarter. MGO One Seven LLC now owns 8,781 shares of the healthcare conglomerate’s stock worth $4,599,000 after buying an additional 30 shares in the last quarter. Finally, Endowment Wealth Management Inc. increased its position in UnitedHealth Group by 5.0% in the 1st quarter. Endowment Wealth Management Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $341,000 after acquiring an additional 31 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $329.78 on Thursday. The company has a market capitalization of $298.73 billion, a price-to-earnings ratio of 17.21, a P/E/G ratio of 2.28 and a beta of 0.47. The firm’s 50 day simple moving average is $343.60 and its 200 day simple moving average is $315.11. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $622.83.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period last year, the business posted $7.15 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Bank of America increased their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Mizuho upped their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Finally, Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.